BioCardia - Warrants (26/07/2022) Other Current Liabilities

As of the most recent data (March 2026), BCDAW shows a other current liabilities of $1.5M. That compares with $1.2M in the prior-year period — up 28.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCDAW's other current liabilities is now $1.5M (was $1.2M) — a 28.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioCardia - Warrants (26/07/2022) is outperforming or lagging.

Tracking BCDAW's other current liabilities over time shows whether BioCardia - Warrants (26/07/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $1.2M in the prior-year period — up 28.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has BioCardia - Warrants (26/07/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.5M) with ownership activity and broader fundamentals.

BioCardia - Warrants (26/07/2022)'s other current liabilities is $1.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.